DK1023266T3 - Fremgangsmåde til fremstilling af diarylpyridiner, der kan anvendes som COX-2-inhibitorer - Google Patents

Fremgangsmåde til fremstilling af diarylpyridiner, der kan anvendes som COX-2-inhibitorer

Info

Publication number
DK1023266T3
DK1023266T3 DK98948426T DK98948426T DK1023266T3 DK 1023266 T3 DK1023266 T3 DK 1023266T3 DK 98948426 T DK98948426 T DK 98948426T DK 98948426 T DK98948426 T DK 98948426T DK 1023266 T3 DK1023266 T3 DK 1023266T3
Authority
DK
Denmark
Prior art keywords
cox
inhibitors
preparation
diaryl pyridines
pyridines
Prior art date
Application number
DK98948426T
Other languages
English (en)
Inventor
Ian W Davies
Linda Gerena
Michel Journet
Robert D Larsen
Philip J Pye
Kai Rossen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806419.9A external-priority patent/GB9806419D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK1023266T3 publication Critical patent/DK1023266T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98948426T 1997-09-25 1998-09-22 Fremgangsmåde til fremstilling af diarylpyridiner, der kan anvendes som COX-2-inhibitorer DK1023266T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6068097P 1997-09-25 1997-09-25
GBGB9806419.9A GB9806419D0 (en) 1998-03-25 1998-03-25 Process for making diaryl pyridines useful as cox-2 inhibitors
PCT/US1998/019788 WO1999015503A2 (en) 1997-09-25 1998-09-22 Process for making diaryl pyridines useful as cox-2 inhibitors

Publications (1)

Publication Number Publication Date
DK1023266T3 true DK1023266T3 (da) 2003-02-24

Family

ID=26313354

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98948426T DK1023266T3 (da) 1997-09-25 1998-09-22 Fremgangsmåde til fremstilling af diarylpyridiner, der kan anvendes som COX-2-inhibitorer

Country Status (15)

Country Link
EP (1) EP1023266B1 (da)
JP (2) JP3325263B2 (da)
CN (1) CN1134415C (da)
AR (1) AR015938A1 (da)
AT (1) ATE230726T1 (da)
AU (1) AU9500298A (da)
BR (1) BR9812837B1 (da)
CZ (1) CZ298850B6 (da)
DE (1) DE69810652T2 (da)
DK (1) DK1023266T3 (da)
EA (1) EA002427B1 (da)
ES (1) ES2189251T3 (da)
HK (1) HK1029343A1 (da)
SK (1) SK283811B6 (da)
WO (1) WO1999015503A2 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50004327D1 (de) * 1999-01-14 2003-12-11 Lonza Ag Verfahren zur herstellung von 1-(6-methylpyridin-3-yl)-2- 4-(methylsulfonyl phenyl)ethanon
KR100446324B1 (ko) 1999-01-14 2004-08-30 론자 아게 1-(6-메틸피리딘-3-일)-2-[4-(메틸술포닐)페닐]에타논 및이의 제조 방법
JP3032980B1 (ja) 1999-06-14 2000-04-17 三協化学株式会社 ２―ピリジルピリジン誘導体の製造方法
WO2001007410A1 (en) * 1999-07-27 2001-02-01 Lonza Ag Process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl) phenyl] ethanone
US6566527B1 (en) * 1999-07-27 2003-05-20 Merck & Co., Inc. Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-methylsulphonyl)-phenyl]ethanone
JP2001115963A (ja) 1999-10-13 2001-04-27 Daikin Ind Ltd 圧縮機
IT1315244B1 (it) * 1999-10-15 2003-02-03 Zambon Spa Processo per la preparazione di intermedi utili nella sintesi didiarilpiridine
IT1315243B1 (it) * 1999-10-15 2003-02-03 Zambon Spa Processo di ossidazione per la preparazione di intermedi utili nellasintesi di diarilpiridine
JP2001261646A (ja) * 2000-03-17 2001-09-26 Sankio Chemical Co Ltd ピリジン誘導体の製造法
JP2001261647A (ja) * 2000-03-22 2001-09-26 Sankio Chemical Co Ltd ピリジン誘導体の製造方法
ATE366569T1 (de) 2000-07-20 2007-08-15 Lauras As Verwendung von cox-2 inhibitoren als immunostimulantien zur behandlung von hiv oder aids
ITMI20012692A1 (it) * 2001-12-19 2003-06-19 Zambon Spa Processo di ossidazione per la preparazione di intermedi utili nella sintesi di diarilpiridine
US7507823B2 (en) 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
ES2683125T3 (es) 2010-06-16 2018-09-25 Glenmark Generics Limited Proceso para la preparación de piridinas 2,3-diaril-5-sustituidas y sus compuestos intermedios
EP2649049B1 (en) * 2010-11-15 2016-08-24 Virdev Intermediates Pvt. Ltd. Process to produce etoricoxib
ITMI20110362A1 (it) 2011-03-09 2012-09-10 F I S Fabbrica Italiana Sint P A Procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib.
CN102276517B (zh) * 2011-06-29 2012-11-28 孙光辉 二芳基吡啶类药物的合成方法
ITMI20111455A1 (it) 2011-07-29 2013-01-30 Italiana Sint Spa Nuovo procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib.
WO2013065064A1 (en) * 2011-10-31 2013-05-10 Sequent Scientific Limited A process for preparation of l-(6-methylpyridin-3-yl)-2-[4-(meth.ylsulfonyi)phenyl]ethanone field of invention
CN103204803A (zh) * 2012-01-13 2013-07-17 阿尔弗雷德·E·蒂芬巴赫尔有限责任两合公司 用于合成依托考昔的方法
ITMI20121947A1 (it) * 2012-11-15 2014-05-16 Erregierre Spa Processo di sintesi di un intermedio nella produzione di etoricoxib
ITVI20130014A1 (it) 2013-01-22 2014-07-23 Italiana Sint Spa Procedimento molto efficiente per preparare un intermedio di etoricoxib
CN104418799A (zh) * 2013-09-03 2015-03-18 天津药物研究院 一种依托考昔的晶型及其制备方法和应用
WO2015036550A1 (en) * 2013-09-13 2015-03-19 Synthon B.V. Process for making etoricoxib
CN104529798B (zh) * 2014-12-10 2016-03-30 齐鲁天和惠世制药有限公司 一种依托考昔中间体3-氨基-2-氯丙烯醛的制备方法
CN107848965B (zh) 2015-07-21 2019-09-24 住友化学株式会社 4-（三氟甲磺酰基）苯酚化合物的制造方法
CN108689917A (zh) * 2017-04-08 2018-10-23 深圳市华先医药科技有限公司 一种依托考昔中间体连续流生产工艺
CN109810052B (zh) * 2017-11-20 2020-06-23 新发药业有限公司 一种高选择性的阿帕替尼的简便制备方法
CN112300061B (zh) * 2020-10-06 2022-02-18 大连理工大学 一种含氮杂环二芳酮化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3277103A (en) * 1961-06-29 1966-10-04 Du Pont beta-amino-alpha-cyanoacroleins and their preparation
US4242515A (en) * 1979-03-28 1980-12-30 American Cyanamid Company Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines
CH660733A5 (de) * 1981-09-29 1987-06-15 Lonza Ag Verfahren zur herstellung von 3-picolin.
DE3634259A1 (de) * 1986-10-08 1988-04-21 Basf Ag Verfahren zur herstellung von substituierten pyridinen
EP0548559A1 (en) * 1991-12-27 1993-06-30 American Cyanamid Company Process for the preparation of dialkyl pyridine -2,3-dicarboxylates and derivatives thereof from dialkyl dichloromaleate
US5686470A (en) * 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation

Also Published As

Publication number Publication date
AR015938A1 (es) 2001-05-30
ES2189251T3 (es) 2003-07-01
CZ20001088A3 (cs) 2000-09-13
EP1023266A2 (en) 2000-08-02
WO1999015503A2 (en) 1999-04-01
WO1999015503A3 (en) 1999-05-20
DE69810652D1 (de) 2003-02-13
JP2001517654A (ja) 2001-10-09
SK4222000A3 (en) 2000-10-09
JP3325263B2 (ja) 2002-09-17
SK283811B6 (sk) 2004-02-03
CN1278795A (zh) 2001-01-03
EA200000358A1 (ru) 2000-10-30
AU9500298A (en) 1999-04-12
ATE230726T1 (de) 2003-01-15
JP2003026687A (ja) 2003-01-29
EA002427B1 (ru) 2002-04-25
BR9812837B1 (pt) 2010-08-24
EP1023266B1 (en) 2003-01-08
JP4157325B2 (ja) 2008-10-01
DE69810652T2 (de) 2003-10-09
HK1029343A1 (en) 2001-03-30
BR9812837A (pt) 2000-08-08
CZ298850B6 (cs) 2008-02-27
CN1134415C (zh) 2004-01-14

Similar Documents

Publication Publication Date Title
DK1023266T3 (da) Fremgangsmåde til fremstilling af diarylpyridiner, der kan anvendes som COX-2-inhibitorer
DK0912537T3 (da) Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorer
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK0912518T3 (da) Substituerede pyridiner som selektive cyclooxygenase-2 inhibitorer
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
IS6289A (is) thríhringja hindrar af poly (ADP-ribosa) polymerösum
DK1213969T3 (da) Metode til overtrækning af levnedsmidler under anvendelse af hydrogeneret isomaltuloseblanding
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
IS5715A (is) Aðferð til smíði á 4-karboxýamínó-2-setnu-1,2,3,4-tetrahýdrókínólíni
DK0950657T3 (da) Substituerede carbazoler, fremgangsmåde til deres fremstilling og deres anvendelse som sPLA2-inhibitorer
DK1279665T3 (da) Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0985733T3 (da) Fremgangsmåde til fremstilling af cyclodextrin
DK1085900T3 (da) Anvendelse af erythropoietin til behandling af primære hæmokromatoser
EE200000568A (et) HIV-proteaasi inhibiitorite valmistamismeetod
DK1131299T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5- eller 3-hydroxypyrazoler
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol
DK0981950T3 (da) Fremgangsm,åde til formering af phyllocactus
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater